retatrutide trial results clinical stage Retatrutide After 40: Realistic Timelines & FAQ Retatrutide FDA Approval Status 2026:

More than a century later, the company became a leader in incretin biology, building the GLP-1/GIP dual agonist tirzepatide (Mounjaro/Zepbound) and following it with retatrutide and orforglipron, its oral non-peptide GLP-1 program

This article is exclusive to STAT+ subscribers Unlock this article plus in-depth analysis, newsletters, premium events, and news alerts

Theres also evidence that GLP-1s affect reward pathways in the brain

Tirzepatide has been shown to significantly reduce inflammatory markers including hsCRP and IL-6 in clinical studies

Medical Doctors (MDs) and Doctors of Osteopathic Medicine (DOs) can prescribe GLP-1 weight loss medications in all 50 states via telehealth, provided theyre licensed in the state where youre physically located during the consultation

Participants taking semaglutide showed significant reductions in major cardiovascular events, including heart attack and stroke, compared to placebo